Featured Press Releases

Ginkgo Technology Network Launches, Providing an Integrated R&D

Ginkgo Technology Network Launches, Providing an Integrated R&D

Mercury Bio

Mercury Bio's new project includes Los Alamos and the National Center for Genome Resources.

  • 23 Jul 2024

Mercury Bio a New Mexico-based biotech company focused on the development of a novel new...

Smart Cups Sets New Goals For Fundraising Round Amid Upcoming Partnerships And Continued Growth

Smart Cups Sets New Goals For Fundraising Round Amid Upcoming Partnerships And Continued Growth

Endo

Endo's New Spatial Computing Injection Simulator for Peyronie's Disease Creates Immersive Learning Environment for Urology Specialists

AbbVie Presents EHA 2026 Data on VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Nine-Year Outcomes

AbbVie Presents EHA 2026 Data on VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Nine-Year Outcomes

Dr. Oregonin Completes U.S. FDA Registration for OLTIS DENTAL-X, Unveiling Oral Care Innovation Rooted in Trans-Pacific Alder Research

Dr. Oregonin Completes U.S. FDA Registration for OLTIS DENTAL-X, Unveiling Oral Care Innovation Rooted in Trans-Pacific Alder Research

Niagen Bioscience Launched Niagen™ Plus Liquid At-Home Injections to Support Its Telehealth Expansion

Niagen Bioscience Launched Niagen™ Plus Liquid At-Home Injections to Support Its Telehealth Expansion

  • Niagen Bioscience, Inc
  • 23 Oct 2026
Aptar Appoints Pharma Packaging Veteran Virginie Maes as President of its Pharma Business

Aptar Appoints Pharma Packaging Veteran Virginie Maes as President of its Pharma Business

  • AptarGroup, Inc.
  • 22 Oct 2026
Zai Lab Reports High Response Rates, Encouraging Durability, and a Favorable Safety Profile for Zocilurtatug Pelitecan (Zoci; Formerly ZL-1310) in First-Line Extensive-Stage Small Cell Lung Cancer

Zai Lab Reports High Response Rates, Encouraging Durability, and a Favorable Safety Profile for Zocilurtatug Pelitecan (Zoci; Formerly ZL-1310) in First-Line Extensive-Stage Small Cell Lung Cancer

  • Zai Lab Limited
  • 22 Oct 2026
Niagen Bioscience Establishes Skincare as a Permanent Tru Niagen® Category with the Launch of Dermatologist-Tested Niagen NanoCloud™ as a Core Product

Niagen Bioscience Establishes Skincare as a Permanent Tru Niagen® Category with the Launch of Dermatologist-Tested Niagen NanoCloud™ as a Core Product

  • Niagen Bioscience, Inc
  • 20 Oct 2026
BD Strengthens Peripheral Vascular Innovation Leadership with Positive AGILITY Trial Results

BD Strengthens Peripheral Vascular Innovation Leadership with Positive AGILITY Trial Results

  • BD
  • 08 Oct 2026
The meeting will focus on Nordic Pharma, Inc.’s patient data and study results on LACRIFILL® Canalicular Gel, a novel ocular surface therapy

The meeting will focus on Nordic Pharma, Inc.’s patient data and study results on LACRIFILL® Canalicular Gel, a novel ocular surface therapy

  • Nordic Pharma, Inc.
  • 08 Oct 2026

Most Popular
October   2026
M T W T F S S
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.